Esther Eleboh: Preventing OHSS in Women with PCOS/PMOS
Esther Eleboh, Reproductive Health Nurse (Head of Nursing Department) at Viva Fertility Clinic, shared on LinkedIn:
“Preventing OHSS in Women with PCOS/PMOS: Every Step Matters
Women with polycystic ovary syndrome (PCOS/PMOS) are at a significantly higher risk of developing ovarian hyperstimulation syndrome (OHSS) during IVF treatment. Fortunately, advances in stimulation protocols have made severe OHSS increasingly preventable.
Current preventive strategies may include:
- Cabergoline, which is generally preferred over bromocriptine because it has stronger evidence for reducing the severity of OHSS and is usually better tolerated.
- Letrozole in selected patients.
- A dual trigger in carefully chosen cases.
- A freeze-all strategy, delaying embryo transfer until a later cycle to avoid the effects of rising hCG levels.
Recently, we managed a patient with PCOS/PMOS who was considered to be at high risk for OHSS. Based on her response to stimulation, she could have progressed to severe OHSS. However, with careful monitoring and the use of preventive measures, her symptoms remained mild, and she recovered well.
This case is a reminder that successful IVF is not only about retrieving many oocytes – it is also about anticipating complications, individualizing treatment, and protecting patient safety.
As reproductive medicine continues to evolve, preventing OHSS should remain one of our highest priorities, especially in women with PCOS/PMOS.
What strategies have you found most effective in minimizing OHSS risk in your clinical practice?”
Stay informed with the latest updates in fertility and reproductive medicine on Fertility News.
-
Nov 14, 2026, 19:27Katy Encalade: Coaching as an Investment in Ethical Leadership
-
Nov 14, 2026, 19:20Jeyarani Kamaraj: 9 Years of Waiting, 2 Heartbreaking Losses, And Today, 2 Tiny Hands to Hold
-
Nov 14, 2026, 19:12Lynn Burmeister: Why Doctor-Owned Fertility Clinics Matter
-
Nov 14, 2026, 18:36Alejandro González: Positive Test 4 Days After Blastocyst Transfer?
-
Nov 14, 2026, 18:29Danilo Cimadomo: Embryo Transfer Is a Means, Not the Objective Itself
-
Nov 14, 2026, 18:15Ryan Flynn: The Role of Psychosexual Medicine in Fertility Care
-
Nov 14, 2026, 18:04Khalil Faaed: Beyond the PB1 – Post-Denudation Oocyte Morphological Assessment in IVF and ICSI
-
Nov 14, 2026, 17:52Christopher Robinson: A Combined Treatment Strategy for Cesarean Scar Ectopic Pregnancy
-
Nov 14, 2026, 17:40Paul Pirtea: Does the Current Evidence Justify Routine Diagnosis and Treatment of Chronic Endometritis?